Stockscreener 앱 받기
20.12
2.13%
0.42
시간 외 거래:
19.90
-0.22
-1.09%
Rigel Pharmaceuticals 주식(RIGL)의 최신 뉴스
17,123 Shares in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Acquired by Dimensional Fund Advisors LP - Defense World
(RIGL) Investment Analysis - news.stocktradersdaily.com
Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) CEO Compensation Looks Acceptable To Us And Here's Why - simplywall.st
Here's Why Rigel (RIGL) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance
Is Rigel Pharmaceuticals (RIGL) a Great Value Stock Right Now? - Yahoo Finance
Wall Street Analysts Think Rigel (RIGL) Could Surge 82.3%: Read This Before Placing a Bet - MSN
Upgrade: Analysts Just Made A Captivating Increase To Their Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Forecasts - Yahoo Finance
Wells Fargo & Company MN Buys 2,648 Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
Cantor Fitzgerald Brokers Reduce Earnings Estimates for RIGL - Defense World
B. Riley Expects Reduced Earnings for Rigel Pharmaceuticals - Defense World
Earnings Estimates Rising for Rigel (RIGL): Will It Gain? - Yahoo Finance
MetLife Investment Management LLC Acquires 2,014 Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
Rigel Pharmaceuticals, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - simplywall.st
Rigel pharmaceuticals targets $200M-$210M revenue in 2025 with strong Q1 performance - MSN
Rigel Pharmaceuticals, Inc. Just Recorded A 370% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance
HC Wainwright Issues Positive Outlook for RIGL Earnings - Defense World
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2025 Earnings Call Transcript - Insider Monkey
Rigel Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Average Rating of “Hold” by Analysts - Defense World
Rigel Pharmaceuticals Reports Strong Growth and Strategic Advances - TipRanks
Rigel Pharmaceuticals: Q1 Earnings Showcase Growing Momentum (NASDAQ:RIGL) - Seeking Alpha
Rigel Pharmaceuticals (RIGL) Price Target Raised by Cantor Fitzg - GuruFocus
Earnings call transcript: Rigel Pharmaceuticals sees stock surge after Q1 2025 earnings - Investing.com Nigeria
Earnings call transcript: Rigel Pharmaceuticals sees stock surge after Q1 2025 earnings By Investing.com - Investing.com South Africa
Rigel Pharma Jump 9.9% Premarket; Guides 'Positive' Net Income in 2025 After Swinging to Profit in Q1 - marketscreener.com
Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Call Highlight - GuruFocus
Rigel Pharmaceuticals Reports Strong Q1 2025 Earnings - TipRanks
Rigel: Q1 Earnings Snapshot - CTPost
Rigel Pharmaceuticals, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:RIGL) - Seeking Alpha
Rigel Pharmaceuticals reports Q1 EPS 63c vs. 47c last year - TipRanks
Rigel Pharmaceuticals reaffirms FY25 revenue $200M-$210M, consensus $197.79M - TipRanks
Rigel Pharmaceuticals (RIGL) Surpasses Q1 Revenue Expectations | - GuruFocus
Rigel Pharmaceuticals Inc Surpasses Q1 2025 Estimates with $0.64 EPS and $53.3 Million Revenue - GuruFocus
Rigel Pharmaceuticals (RIGL) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
RIGL Projects Strong Financial Outlook for FY25 | RIGL Stock New - GuruFocus
Rigel Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Rigel Reports First Quarter 2025 Financial Results and Provides Business Update - Longview News-Journal
Rigel Pharmaceuticals Q1 25 Earnings Conference Call AT 4:30 PM ET - Nasdaq
Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus
Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update - Kilgore News Herald
Rigel Announces Conference Call and Webcast to Report First Quar - GuruFocus
Rigel Pharmaceuticals Sets Key Q1 2025 Earnings Date: How to Access Latest Biotech Results - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
2.33%
1.09%
자본화:
|
볼륨(24시간):